Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder
Conclusions
Switching to suvorexant or eszopiclone was well tolerated and improved the severity of benzodiazepine-unresponsive insomnia in MDD patients. Both drugs could be beneficial alternatives to benzodiazepines for treating insomnia in MDD patients.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research
More News: Anxiety | Brain | Depression | Eszopiclone | Generalized Anxiety Disorder (GAD) | Insomnia | Japan Health | Lunesta | Neurology | Sleep Disorders | Sleep Medicine | Study